Stock Comparison
BMY vs JNJ
Bristol-Myers Squibb Company and Johnson & Johnson side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$131.77B
$626.01B
P/E (TTM)
14.2
30.1
Forward P/E
9.4
22.3
Price/Sales
2.7
6.4
Price/Book
5.9
7.4
EV/EBITDA
9.9
19.3
Dividend Yield
2.91%
2.00%
Profitability
Net Margin
15.01%
21.83%
Operating Margin
25.67%
26.87%
Return on Equity
46.60%
25.70%
Return on Assets
10.70%
8.60%
Growth (YoY)
Revenue Growth
5.70%
6.60%
Earnings Growth
153.10%
-0.90%
Price & Risk
Beta
0.2
0.2
52-Week High
$65.90
$267.34
52-Week Low
$41.66
$170.46
Analyst Target
$66.21
$272.50
Compare BMY and JNJ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.